Drug Delivery Systems by Chemical Modification of Bioactive Molecules.
نویسندگان
چکیده
منابع مشابه
Silk-based delivery systems of bioactive molecules.
Silks are biodegradable, biocompatible, self-assembling proteins that can also be tailored via genetic engineering to contain specific chemical features, offering utility for drug and gene delivery. Silkworm silk has been used in biomedical sutures for decades and has recently achieved Food and Drug Administration approval for expanded biomaterials device utility. With the diversity and control...
متن کاملNovel transdermal drug delivery systems
Background and aim: Eczema is a common inflammatory skin disease. Although history and physical examination are important in diagnosis of allergen, because of extent of environmental allergens, those are not simply recognized. The objective of this study was to determine allergens in patients with contact or atopic dermatitis referred to Razi hospital.Materials and Meth...
متن کاملSelf Assembly Systems for Surface Modification and Drug Delivery
Self-assembled monolayers (SAMs) are ordered molecular assemblies that form spontaneously by the adsorption of a surfactant with a specific affinity of its headgroup to a substrate. The present work aims at developing a new monomolecular PEG-based adlayer system and its protein resistance properties, by exploiting the spontaneous formation of alkane phosphate SAMs on titanium oxide and their ca...
متن کاملModification of mesoporous silica SBA-15 with different organic molecules to gain chemical sensors: a review
The recognition of the biologically and environmentally important ions is of great interest in the field of chemical sensors in recent years. The fluorescent sensors as a powerful optical analytical technique for the detection of low level of various analytes such as anions and metal cations have been progressively developed due to the simplicity, cost effective, and selectivity for monitoring ...
متن کاملComputational Study of Anticancer Dasatinib for Drug Delivery Systems
Dasatinib is a tyrosine kinase inhibitor (TKI) that is used to treat chronic myeloid leukemiaand in the management of ulcerative colitis (UC) and to provide appropriate results in treatment. Dasatinib is significantly higher and faster than full cytogenetic and large molecular responses as compared to imatinib. In the recent study, using the NMR data, thermochemical properties of the dasa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kobunshi
سال: 1999
ISSN: 0454-1138,2185-9825
DOI: 10.1295/kobunshi.48.578